Chemomab Therapeutics Ltd. Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Chemomab Therapeutics Ltd. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q2 2024.
  • Chemomab Therapeutics Ltd. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 287M shares, a 15.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 287M +39.1M +15.8% Jun 30, 2024 6-K 2024-08-21
Q4 2023 284M +51.5M +22.1% Dec 31, 2023 6-K 2024-08-21
Q2 2023 248M +19.4M +8.5% Jun 30, 2023 6-K 2023-08-14
Q1 2023 233M +4.55M +1.99% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 233M +4.55M +1.99% Dec 31, 2022 6-K 2023-08-14
Q3 2022 229M +1.06M +0.47% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 229M +677K +0.3% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 228M +14.1M +6.6% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 228M +219M +2359% Dec 31, 2021 10-Q 2022-11-10
Q3 2021 228M +191M +514% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 228M +191M +514% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 214M +177M +477% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 9.27M -27.8M -75% Dec 31, 2020 10-Q 2021-11-12
Q3 2020 37.1M Sep 30, 2020 10-Q 2020-11-16
Q2 2020 37.1M Jun 30, 2020 10-Q 2020-08-14
Q1 2020 37.1M Mar 31, 2020 10-Q 2020-05-07
Q4 2019 37.1M +21.5M +138% Dec 31, 2019 10-K 2021-03-09
Q4 2018 15.6M Dec 31, 2018 10-K 2020-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.